TeraLumen Solutions

⚠️Important Notice: Fraudulent Emails Alert – Click Here for Details

Terahertz Technology

An Innovative Terahertz-Based Real-Time Tissue Imaging Device for Surgical Guidance

Cancer Cases

1
8
7
4
1
9
9
7

Cancer Deaths

3
4
1
9
8
8
7
7

Approximately > 3,90,000 cancer surgeries in a year in India

Number of failure surgeries >20%

Conventional Process : Pathology Assessment

Patient

Primary Sample

Snap Freezing

Slides

Microscope

Oncologists

Apply OCT Fluid

Tissue Blocks

Set of Slides

Pathologist

Conventional Process : Pathology Assessment

Patient

Oncologists

Primary Sample

Apply OCT Fluid

Snap Freezing

Tissue Blocks

Slides

Set of Slides

Microscope

Pathologist

Current diagnostic procedure  “Frozen Section Analysis” is conventionally used in hospitals. It requires freezing the tissue, slicing and then waiting for an  pathologist for the confirmation.

Most of the small and medium hospitals rely on Histopathology analysis, which takes 5 to 7 days depending on the availability of the pathologists.

Current Approach

  • Time Consuming
  • Need of expert Pathologist
  • Postoperative Procedure
  • Recurrence

TeraMargin™

An Alternate potential reagent free solution for Accurate Cancer Margin Detection

Combining cutting edge Terahertz Technology, with Advanced Machine Learning to transform cancer surgery

Precise

Reagents Free

Rapid (Within 10 mins)

Tera Margin Process

Patient

IMAGING TeraMargin

Oncologists

Primary Sample

Machine learning

Tera Margin Process

Patient

IMAGING TeraMargin

Oncologists

Primary Sample

Machine learning

TeraMargin™ Validated with

100+ Head and Neck Fresh
tissue samples

75+ Breast Cancer
Tissue Samples

TeraLumen Has Developed

TeraMargin

TeraMargin, a patented device, can precisely segment regions with and without tumors while performing real-time imaging without touching the tissue.

TeraSoft

In-built Graphical User Interface to display the real time tissue images, mapped with visible image

 

Clinical Decision

We are attempting to utilize our cutting-edge artificial intelligence algorithm to attain sensitivity and specificity of above 90 percent.

 

Collaborators